Posters ECNP Workshop 2013
P.1 Molecular neuropsychopharmacology
P.1.001
3-nitropropionic acid induces autophagy by forming mitochondrial permeability transition pore, not by activating mitochondrial fission
Mª de la Encarnación Solesio Torregrosa, Spain
P.1.002
Pharmacological characterisation of positive allosteric modulators acting on the metabotropic glutamate receptor 2
Kirstie Bennett, United Kingdom
P.1.004
RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis
Albert Ferrés-Coy, Spain
P.1.005
Role of cannabinoid CB1 receptors in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats
Valentina Licheri, Italy
P.1.007
A proteomic and functional analysis reveals that 5-HT6 receptors modulate neuronal differentiation by recruitment of Cdk5
Fanny Duhr, France
P.1.009
Cell synchronisation as a tool to optimise expression of metabotropic glutamate receptors in inducible mammalian expression system
Barbara Chruscicka, Poland
P.1.010
The identification of protein tyrosine phosphatase, non-receptor type 1 in hippocampal modulation of food anticipatory behaviour
Elzbieta Kostrzewa, The Netherlands
P.1.011
Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis
Irina Ionescu, Germany
P.1.012
Stress-induced vulnerability of presynaptic glutamatergic terminals and effect of desipramine
Nicoletta Nava, Denmark
P.1.013
Chronic (-)cannabidiol produces antidepressant-like effects in bulbectomised mice acting on 5-HT1A and CB1 receptors functionality
Raquel Linge, Spain
P.1.014
Intracerebroventricular administration of interleukin-1ß elevates brain kynurenic acid and disrupts PPI in C57BL/6 mice
Markus Larsson, Sweden
P.1.016
Modulation of dopamine D2L and D3 receptor signalling and cell surface-cytosol trafficking by dysbindin in CHO cells
Nathalie Schmieg, France
P.1.017
Histaminergic regulation of presumed serotonin neurons in the dorsal raphe nucleus
Kara Panetta, United Kingdom
P.1.020
The role of CREB/ BDNF/ TrkB signaling in the zinc deficiency model of depression
Urszula Doboszewska, Poland
P.1.021
Chronic administration of haloperidol in rats and its effect on microglial cell density and whole brain weight and volume
Peter Bloomfield, United Kingdom
P.1.022
Role of trace amine-associated receptor 1 (TAAR1) in the modulation of dopaminergic system and cortico-striatal signalling
Stefano Espinoza, Italy
P.1.023
Survival role of embryonal proteins in Alzheimer's disease linked dementia via regulation of oxidative stress and level of catecholamines
Konstantin Yenkoyan, Rep. of Armenia
P.1.024
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction
Claudia Sagheddu, Italy
P.2 Behavioural pharmacology
P.2.001
Citalopram given to stressed and control pregnant rats causes sex-dependent changes in behaviour and CRH mRNA expression in their offspring
Inbar Zohar, Israel
P.2.002
Behavioural, molecular and glutamatergic changes in a developmental model of schizophrenia, and reversal by a 5-HT6 receptor antagonist
Madeleine King, United Kingdom
P.2.003
Sub-anesthetic ketamine modulates intrinsic BOLD connectivity between the hippocampus and the prefrontal cortex in the rat
Natalia Gass, Germany
P.2.004
The dopamine ß-hydroxylase inhibitor nepicastat suppresses different chocolate-motivated behaviours in rats
Alessandro Zaru, Italy
P.2.005
The trans-isomer of resveratrol acutely improves motivation in rat
Janko Samardzic, Serbia
P.2.006
Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behaviour in rats
Joanna Miszkiel, Poland
P.2.007
Tryptophan depletion impairs emotion recognition in healthy women
Michaela Defrancesco, Austria
P.2.008
5XFAD mouse model of Alzheimer's disease: a dissociation between brain pathology and behavioural phenotype
Katrin Sonn, Estonia
P.2.009
Effect of early life experiences on brain structure and function: neurogenesis and decision making
Manila Loi, The Netherlands
P.2.011
GluA1 and its Postsynaptic density protein 95(PSD-95)/Discs large/Zonula occludens-1 (PDZ)-interaction: a role in experience-dependent behavioural plasticity in the forced swim test
Florian Freudenberg, Germany
P.2.012
Chronic modulation of 5-HT4 and 5-HT6 serotonergic receptors: a new hope to treat cognitive deficits?
Anne Quiedeville, France
P.2.015
Low performing rats model the inattentive subtype of adult ADHD in the 5-choice continuous performance task (5C-CPT)
Anneka Tomlinson, United Kingdom
P.2.016
Exposure to an alternative reward does not reduce cocaine-seeking behaviour
Céline Nicolas, France
P.2.017
The hallucinogen 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) disrupts cortical function: reversal by antipsychotic drugs
Maurizio Riga, Spain
P.2.018
Characterisation of the effects of partial agonist of a4ß2* nACh receptor cytisine in the two-choice serial reaction time task
Gleb Makshakov, Russia
P.2.019
The mismatch hypothesis: a new way of linking early experiences and adult environment to vulnerability to stress
Sara Santarelli, Germany
P.2.020
Disruption of 5-HT7 receptors accelerates age-related episodic-like memory decline
Gregory Beaudet, France
P.2.021
Role of adenosine (A)2A receptor in nicotine addiction pharmacological and genetic aspects
Joanna Czyzyk, Poland
P.2.022
Oxytocin in the central nucleus of the amygdala mediates social buffering of fear
Elizabeth Rickenbacher, Portugal
P.2.023
The antagonist of 5-HT7 receptors, SB-269970, and amisulpride reverses ketamine-induced cognitive inflexibility in rats
Dominik Rafa, Poland
P.2.024
The effects of positive allosteric modulators of a7 nicotinic receptors on rats' performance in the odor span test
Agnieszka Potasiewicz, Poland
P.2.026
Pro-inflammatory cytokines induce anhedonia in mice and increase monoamine transporter activity in the nucleus accumbens
Floor van Heesch, The Netherlands
P.2.027
a7 nicotinic acetylcholine receptor (a7 nAChR) agonists or antagonists as potential cognition enhancers?
Nick van Goethem, The Netherlands
P.2.030
Nutritional variables are associated with attention and impulsivity in stimulant-dependence
Claire Whitelock, United Kingdom
P.2.033
Does serotonin depletion augment or counteract the aggression-provoking effect of testosterone in mice?
Erik Studer, Sweden
P.2.035
'Anxious' rats exhibit an enhanced anxiogenic response to acute SSRI treatment and indices of heightened serotonergic transmission
Jakob Näslund, Sweden
P.3 Clinical neuropsychopharmacology
P.3.001
Valproic acid treatment prevents the development of deficit in sensorimotor gating in adult prenatally MAM treated rats
Joachim Latusz, Poland
P.3.002
The effect of valproic acid on changes in methylation pattern of histone H3 induced by prenatal MAM administration in mPFC
Ewelina Bator, Poland
P.3.004
Possible interplay between BDNF and dynorphin in bipolar disorder: role of epigenetic mechanisms
Andrea Di Francesco, Italy
P.3.007
Stress induced miRNA changes in depression: peripheral biomarker or pathophysiology?
Sara Kalman, Hungary
P.3.010
Time-dependent effects of antidepressant treatments on miRNome expression profile in hippocampus of rats
Mara Seguini, Italy
P.4 Depression: towards new drug targets
P.4.001
Clinical implications of polarity index of drugs in maintenance treatment of bipolar disorder: a naturalistic study
Dina Popovic, Spain
P.4.003
Publication pressure and burn out among Dutch medical professors: a nationwide survey
Joeri Tijdink, The Netherlands
P.4.004
Early onset of lithium prophylaxis as possible good prognostic factor for staging bipolar disorder
Silvia Brioschi, Italy
P.4.005
Effects of cigarette smoking on schizophrenia treatment with olanzapine
Katarina Zoric, Serbia
P.4.007
Associations of antiepileptic drugs with anxiety and depressive symptoms in pediatric epilepsy: a pilot study
Dejan Stevanovic, Serbia
P.4.009
Age at onset and cognitive impairment in schizophrenia: an ecological cross-sectional study with stabilised patients
Alice Caldiroli, Italy
P.4.010
Association of personality features with lithium prophylactic response
Daria Dembinska-Krajewska, Poland
P.4.012
Effects of second generation antipsychotics on cognitive domains measured with the Matrics Consensus Cognitive Battery in early psychoses
Itziar Montalvo, Spain
P.4.014
Fear conditioning and context learning in relation to treatment outcome: a study in patients with panic disorder and social phobia
Puck Duits, The Netherlands
P.4.015
Long term therapy with methylphenidate induces modest effects on growth in adhd children
Carla Balia, Italy
P.4.016
Regional differences of SERT occupancy in major depression: an in vivo PET study using [11C]DASB
Pia Baldinger, Austria
P.4.018
General error monitoring system dysfunction in obsessive compulsive disorder patients: an event related potential study
Lior Carmi, Israel
P.4.019
Insight and recovery in schizophrenic patients: an observational study
Dario Cannavò, Italy
P.4.023
Habenular nuclei in different phases of major depressive disorder: a magnetic resonance imaging volumetric study
Javier De Diego-Adeliño, Spain
P.4.027
Six-month follow-up study of repetitive transcranial magnetic stimulation in the treatment of resistant major depressive disorder
Carmen Concerto, Italy
P.4.029
Antioxidant status and fatty acids in adolescents with Asperger syndrome and first episodes of early-onset psychosis
Maria Goretti Moron-Nozaleda, Spain
P.4.030
Bright light dose correlates with change in striatal serotonin transporter binding in healthy Scandinavians
Brenda Elvira Munk Mc Mahon, Denmark
P.4.031
Effects of mental distress on cognitive functioning in patients admitted for cardiac rehabilitation after acute coronary events
Julius Burkauskas, Lithuania
P.4.032
Neuroinflammation in temporal cortex in schizophrenia patients
Thalia van der Doef, The Netherlands
P.4.033
Cerebrospinal fluid biomarkers of brain injury in bipolar disorder
Joel Jakobsson, Sweden
P.4.034
Glucose abnormalities in newly diagnosed, medication-naïve patients with bipolar disorder, mania, and psychosis
Clemente Garcia-Rizo, Spain
P.4.038
Effect of neuregulin-1 gene functional variant and environmental factors on alcohol use disorder
Mariliis Vaht, Estonia
